A detailed history of Agf Investments LLC transactions in Incyte Corp stock. As of the latest transaction made, Agf Investments LLC holds 23,593 shares of INCY stock, worth $1.65 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
23,593
Previous 12,507 88.64%
Holding current value
$1.65 Million
Previous $950,000 65.47%
% of portfolio
0.14%
Previous 0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$66.18 - $82.86 $733,671 - $918,585
11,086 Added 88.64%
23,593 $1.57 Million
Q2 2022

Aug 12, 2022

BUY
$66.18 - $83.18 $42,090 - $52,902
636 Added 5.36%
12,507 $950,000
Q1 2022

May 10, 2022

BUY
$66.02 - $79.71 $783,723 - $946,237
11,871 New
11,871 $943,000
Q4 2021

Feb 01, 2022

SELL
$63.34 - $74.11 $519,388 - $607,702
-8,200 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$68.67 - $84.02 $63,039 - $77,130
918 Added 12.61%
8,200 $564,000
Q2 2021

Aug 12, 2021

SELL
$79.87 - $87.53 $59,902 - $65,647
-750 Reduced 9.34%
7,282 $613,000
Q1 2021

May 14, 2021

SELL
$76.02 - $100.5 $96,849 - $128,037
-1,274 Reduced 13.69%
8,032 $653,000
Q4 2020

Feb 08, 2021

SELL
$80.74 - $97.7 $425,176 - $514,488
-5,266 Reduced 36.14%
9,306 $809,000
Q3 2020

Nov 12, 2020

BUY
$85.07 - $109.69 $990,725 - $1.28 Million
11,646 Added 398.02%
14,572 $1.31 Million
Q2 2020

Aug 11, 2020

SELL
$74.18 - $108.93 $40,873 - $60,020
-551 Reduced 15.85%
2,926 $304,000
Q1 2020

May 08, 2020

BUY
$63.18 - $85.97 $6,760 - $9,198
107 Added 3.18%
3,477 $255,000
Q4 2019

Feb 12, 2020

BUY
$73.04 - $95.72 $132,348 - $173,444
1,812 Added 116.3%
3,370 $294,000
Q3 2019

Nov 12, 2019

BUY
$72.82 - $86.52 $113,453 - $134,798
1,558 New
1,558 $116,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Agf Investments LLC Portfolio

Follow Agf Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments LLC with notifications on news.